These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 37319369)

  • 21. The Prospect of Biomimetic Immune Cell Membrane-Coated Nanomedicines for Treatment of Serious Bacterial Infections and Sepsis.
    Hoffman A; Nizet V
    J Pharmacol Exp Ther; 2024 May; 389(3):289-300. PubMed ID: 38580449
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Coating nanoparticles with cell membranes for targeted drug delivery.
    Gao W; Zhang L
    J Drug Target; 2015; 23(7-8):619-26. PubMed ID: 26453159
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Application of Biomimetic Nanoparticles based on the Cell Membrane in Tumor Therapy.
    Gong Y; Huang J
    Curr Top Med Chem; 2023; 23(10):907-920. PubMed ID: 37102484
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Biomimetic nanoarchitecturing: A disguised attack on cancer cells.
    Jha A; Nikam AN; Kulkarni S; Mutalik SP; Pandey A; Hegde M; Rao BSS; Mutalik S
    J Control Release; 2021 Jan; 329():413-433. PubMed ID: 33301837
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anti-EGFR-iRGD recombinant protein modified biomimetic nanoparticles loaded with gambogic acid to enhance targeting and antitumor ability in colorectal cancer treatment.
    Zhang Z; Qian H; Huang J; Sha H; Zhang H; Yu L; Liu B; Hua D; Qian X
    Int J Nanomedicine; 2018; 13():4961-4975. PubMed ID: 30214200
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Functionalized biomimetic nanoparticles combining programmed death-1/programmed death-ligand 1 blockade with photothermal ablation for enhanced colorectal cancer immunotherapy.
    Xiao Y; Zhu T; Zeng Q; Tan Q; Jiang G; Huang X
    Acta Biomater; 2023 Feb; 157():451-466. PubMed ID: 36442821
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cell membrane-based biomimetic nanosystems for advanced drug delivery in cancer therapy: A comprehensive review.
    Zhao J; Ruan J; Lv G; Shan Q; Fan Z; Wang H; Du Y; Ling L
    Colloids Surf B Biointerfaces; 2022 Jul; 215():112503. PubMed ID: 35429736
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Biomimetic cell-derived nanocarriers for modulating immune responses.
    Qin M; Du G; Sun X
    Biomater Sci; 2020 Jan; 8(2):530-543. PubMed ID: 31750453
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Targeting drugs to tumours using cell membrane-coated nanoparticles.
    Fang RH; Gao W; Zhang L
    Nat Rev Clin Oncol; 2023 Jan; 20(1):33-48. PubMed ID: 36307534
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Macrophage-cancer hybrid membrane-coated nanoparticles for targeting lung metastasis in breast cancer therapy.
    Gong C; Yu X; You B; Wu Y; Wang R; Han L; Wang Y; Gao S; Yuan Y
    J Nanobiotechnology; 2020 Jun; 18(1):92. PubMed ID: 32546174
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Size Dependency of Circulation and Biodistribution of Biomimetic Nanoparticles: Red Blood Cell Membrane-Coated Nanoparticles.
    Li H; Jin K; Luo M; Wang X; Zhu X; Liu X; Jiang T; Zhang Q; Wang S; Pang Z
    Cells; 2019 Aug; 8(8):. PubMed ID: 31412631
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genetically Engineered Plasma Membrane Nanovesicles for Cancer-Targeted Nanotheranostics.
    Zhang P; Chen H; Liu J; Liu G
    Methods Mol Biol; 2019; 2054():283-294. PubMed ID: 31482462
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The potential of biomimetic nanoparticles for tumor-targeted drug delivery.
    Li B; Wang F; Gui L; He Q; Yao Y; Chen H
    Nanomedicine (Lond); 2018 Aug; 13(16):2099-2118. PubMed ID: 30226404
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Red Blood Cell Membrane as a Biomimetic Nanocoating for Prolonged Circulation Time and Reduced Accelerated Blood Clearance.
    Rao L; Bu LL; Xu JH; Cai B; Yu GT; Yu X; He Z; Huang Q; Li A; Guo SS; Zhang WF; Liu W; Sun ZJ; Wang H; Wang TH; Zhao XZ
    Small; 2015 Dec; 11(46):6225-36. PubMed ID: 26488923
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cell membrane-coated nanoparticles: a novel multifunctional biomimetic drug delivery system.
    Liu H; Su YY; Jiang XC; Gao JQ
    Drug Deliv Transl Res; 2023 Mar; 13(3):716-737. PubMed ID: 36417162
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Biomimetic platelet membrane-coated nanoparticles for targeted therapy.
    Han H; Bártolo R; Li J; Shahbazi MA; Santos HA
    Eur J Pharm Biopharm; 2022 Mar; 172():1-15. PubMed ID: 35074554
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Erythrocyte-cancer hybrid membrane-coated reduction-sensitive nanoparticles for enhancing chemotherapy efficacy in breast cancer.
    Rezaei S; de Araújo Júnior RF; da Silva ILG; Schomann T; Eich C; Cruz LJ
    Biomater Adv; 2023 Aug; 151():213456. PubMed ID: 37196459
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cell membrane biomimetic nanoparticles for inflammation and cancer targeting in drug delivery.
    Wang H; Liu Y; He R; Xu D; Zang J; Weeranoppanant N; Dong H; Li Y
    Biomater Sci; 2020 Jan; 8(2):552-568. PubMed ID: 31769765
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Biomimetic anisotropic polymeric nanoparticles coated with red blood cell membranes for enhanced circulation and toxin removal.
    Ben-Akiva E; Meyer RA; Yu H; Smith JT; Pardoll DM; Green JJ
    Sci Adv; 2020 Apr; 6(16):eaay9035. PubMed ID: 32490199
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cell membrane-encapsulated magnetic nanoparticles for enhancing natural killer cell-mediated cancer immunotherapy.
    Wu D; Shou X; Zhang Y; Li Z; Wu G; Wu D; Wu J; Shi S; Wang S
    Nanomedicine; 2021 Feb; 32():102333. PubMed ID: 33188908
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.